Vorasidenib
servier
['vorasidenib']
vorasidenib delays disease progression or death in patients with grade 2 idh-mutated glioma 
Physician-Scientist; Med-Onc; Pubs https://t.co/8RMRruPhfx Director @BrownUCancer Assoc Dean @BrownMedicine @americancancer Professor; Inventor, Entrepreneur